iBio
IBIO
#9393
Rank
A$0.11 B
Marketcap
A$3.39
Share price
0.84%
Change (1 day)
-37.22%
Change (1 year)

Market capitalization of iBio (IBIO)

Market cap: A$0.11 Billion

As of February 2026 iBio has a market cap of A$0.11 Billion. This makes iBio the world's 9393th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of iBio from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.11 B84.55%
2025A$63.45 M76.07%
2024A$36.03 M793.85%
2023A$4.03 M-31.42%
2022A$5.87 M-96.44%
2021A$0.16 B-42.92%
2020A$0.28 B1390.11%
2019A$19.4 M-3.67%
2018A$20.14 M-22.99%
2017A$26.15 M-46.43%
2016A$48.83 M-17.85%
2015A$59.44 M-1.34%
2014A$60.24 M148.94%
2013A$24.2 M-15.07%
2012A$28.49 M8.72%
2011A$26.21 M-73.91%
2010A$0.10 B254.65%
2009A$28.32 M711.37%
2008A$3.49 M

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of iBio was reported to be:

A$0.11 Billion
by Nasdaq info icon info icon
A$0.11 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$837.44 B 715,039.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A$0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$2.83 B 2,320.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.81 B 592.43%๐Ÿ‡บ๐Ÿ‡ธ USA